Company
4D Molecular Therapeutics
4D Molecular Therapeutics has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| 4D-150 IVT (3x10^10 vg) | Phase 3 | Diabetic Macular Edema (DME) |
Latest
No recent events.
Follow 4D Molecular Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.